Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.
May 10, 2022
0
0
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.
May 10, 2022
0
0
A March report says climate change is extending the pollen and mold allergy season and making it more intense.
Mar 27, 2023
0
21
Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain. This treatment approach, which is used to target drugs ...
Oct 21, 2016
0
139
Ketamine is a darling of combat medics and clubgoers, an anesthetic that can quiet your pain without suppressing breathing and a hallucinogenic that can get you high with little risk of a fatal overdose.
Jun 17, 2019
0
8
The 2021 flu season is hitting us at the same time that millions of Americans are considering a COVID-19 booster vaccination.
Sep 23, 2021
0
20
(HealthDay)—An expert panel for the U.S. Food and Drug Administration has endorsed a drug for major depressive disorder that is a close relative to ketamine.
Feb 14, 2019
0
1
Could smoking pot somehow help keep sinus problems at bay?
Aug 1, 2022
0
2
Does the flu vaccine affect my chances of getting COVID-19?
Oct 15, 2020
0
2
SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed ...
Apr 16, 2022
0
4
Q: Does it matter which flu vaccine my children get this year and when they get it?
Nov 22, 2021
0
2